Teva Pharmaceutical Industries Ltd - Company Profile
Powered by 
All the sales intelligence you need on Teva Pharmaceutical Industries Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Teva Pharmaceutical Industries Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Teva Pharmaceutical Industries Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Teva Pharmaceutical Industries Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Teva Pharmaceutical Industries Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Sol J. Barer, Ph.D.
Chairman Executive BoardDr. Sol J. Barer has been the Chairman of the company since 2017. Prior to this, he served on the Board of Directors of Contrafect. Previously, he served as the Chairman of NexImmune Inc. Dr. Barer served as the founder of the biotechnology group at the chemical company Celanese Corp. Currently, he also serves as the Managing Partner of SJ Barer Consulting and Advisor to the Israel Biotech Fund.
Richard D. Francis
Director; President; Chief Executive Officer Executive BoardMr. Richard D. Francis has been the President, Chief Executive Officer, and Director of the company since 2023. Prior to this, he served as the Chief Executive Officer of Purespring Therapeutics. Mr. Francis also served as the Chief Executive Officer of Forcefield Therapeutics. Previously, he served as the Chief Executive Officer of Sandoz.
Eli Kalif
Executive Vice President; Chief Financial Officer Senior ManagementMr. Eli Kalif has been the Executive Vice President and Chief Financial Officer of the company since 2019. Prior to this, he served as the Senior Vice President, Finance of Flex. Mr. Kalif also served as the Audit Manager at Deloitte.
Eric A. Hughes, MD
Executive Vice President - Global R&D; Chief Medical Officer Senior ManagementDr. Eric A. Hughes has been the Executive Vice President, Global R&D and Chief Medical Officer of the company since 2022. Prior to this, he served as the Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals. Dr. Hughes also served as the Head of the Immunology, Hepatology, and Dermatology Global Development Unit of Novartis.
Nir Baron
Chief Internal Auditor; Senior Vice President Senior ManagementMr. Nir Baron has been the Senior Vice President and Chief Internal Auditor of the company since 2014. Prior to this, he served as the Director of Investigations and Intelligence and a Member of the management team of the Israel Securities Authority (ISA) from 2007 through 2012. Mr. Baron also served in various investigatory and managerial roles in the ISA, including Deputy Director of the Department of Investigations from 2001 to 2007.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer